These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35163122)

  • 1. Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma.
    Zumaya ALV; Rimpelová S; Štějdířová M; Ulbrich P; Vilčáková J; Hassouna F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated PAMAM dendrimers loading oxaliplatin with prolonged release and high payload without burst effect.
    Ho MN; Bach LG; Nguyen DH; Nguyen CH; Nguyen CK; Tran NQ; Nguyen NV; Hoang Thi TT
    Biopolymers; 2019 Jul; 110(7):e23272. PubMed ID: 30897210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
    Rafiei P; Haddadi A
    Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-based nanocarriers for combined delivery of colchicine and purpurin 18 in cancer therapy: Multimodal approach employing cancer cell spheroids.
    Zumaya ALV; Pavlíčková VS; Rimpelová S; Štějdířová M; Fulem M; Křížová I; Ulbrich P; Řezanka P; Hassouna F
    Int J Pharm; 2024 May; 657():124170. PubMed ID: 38679244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/carboxymethylcellulose-stabilized poly(lactide-co-glycolide) particles as bio-based drug delivery carriers.
    Inphonlek S; Sunintaboon P; Léonard M; Durand A
    Carbohydr Polym; 2020 Aug; 242():116417. PubMed ID: 32564826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: an insight into nano delivery system.
    Yaghoubi N; Gholamzad A; Naji T; Gholamzad M
    BMC Biotechnol; 2024 Aug; 24(1):52. PubMed ID: 39095760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
    Rafiei P; Haddadi A
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
    Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
    Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.
    Joung YK; Son S; Jang JY; Kwon MH; Park KD
    Pharm Res; 2012 Apr; 29(4):932-42. PubMed ID: 22139535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma.
    Bakhaidar R; O'Neill S; Ramtoola Z
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
    Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.